WINRHO SDF (Rho(D) immune globulin/maltose)
IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
CANGENE BIOPHAR
Indication
Prevention of Rh incompatibility reaction
Prevention of Rh incompatibility reaction refers to immunoprophylaxis aimed at averting maternal alloimmunization, or isoimmunization, in Rh-negative individuals exposed to Rh-positive red blood cells. Read more about Prevention of Rh incompatibility reaction
7 drugs 7 manufacturers
Drugs that treat it
Common Prevention of Rh incompatibility reaction therapies.
WINRHO SDF (Rho(D) immune globulin/maltose)
IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
BAXTER BIOSCIEN
RHOPHYLAC (Rho(D) immune globulin)
RHO(D) IMMUNE GLOBULINS·IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
CSL Behring
WINRHO SDF (Rho(D) immune globulin/maltose)
IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
APTEVO BIOTHERA
WINRHO SDF (Rho(D) immune globulin/maltose)
IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
BAXALTA US INC.
WINRHO SDF (Rho(D) immune globulin/maltose)
IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
SAOL THERAPEUTI
WINRHO SDF (Rho(D) immune globulin/maltose)
RHO(D) IMMUNE GLOBULINS·IDIOPATHIC THROMBOCYTOPENIC PURPURA·+3
KAMADA LTD.
Filter & compare in the drug finder →Opens the drug finder with Prevention of Rh incompatibility reaction preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of Rh incompatibility reaction refers to immunoprophylaxis aimed at averting maternal alloimmunization, or isoimmunization, in Rh-negative individuals exposed to Rh-positive red blood cells.
This clinical scenario predominantly occurs during pregnancy or delivery when fetal erythrocytes carrying the Rh(D) antigen enter the maternal bloodstream, but it can also follow accidental transfusion of Rh-incompatible blood components.
Without intervention, the recipient’s immune system recognizes the foreign D antigen and produces anti-D antibodies, which can cross the placenta in subsequent pregnancies to induce immune-mediated hemolysis, severe fetal anemia, hydrops fetalis, and hemolytic disease of the fetus and newborn.
Prophylactic management specifically targets unsensitized Rh-negative pregnant individuals, or non-immunized transfusion recipients, to block this humoral immune response before active antibody formation occurs.
- rhophylac.com
Prevention of Rh incompatibility reaction refers to immunoprophylaxis aimed at averting maternal alloimmunization, or isoimmunization, in Rh-negative individuals exposed to Rh-positive red blood cells This clinical scenario predominantly occurs during pregnancy or delivery when fetal erythrocytes carrying the Rh(D) antigen enter the maternal bloodstream, but it can also follow accidental transfusion of Rh-incompatible blood components
- nih.gov
Prevention of Rh incompatibility reaction refers to immunoprophylaxis aimed at averting maternal alloimmunization, or isoimmunization, in Rh-negative individuals exposed to Rh-positive red blood cells This clinical scenario predominantly occurs during pregnancy or delivery when fetal erythrocytes carrying the Rh(D) antigen enter the maternal bloodstream, but it can also follow accidental transfusion of Rh-incompatible blood components Without intervention, the recipient’s immune system recognize...
- medlineplus.gov
Without intervention, the recipient’s immune system recognizes the foreign D antigen and produces anti-D antibodies, which can cross the placenta in subsequent pregnancies to induce immune-mediated hemolysis, severe fetal anemia, hydrops fetalis, and hemolytic disease of the fetus and newborn
- nih.gov
Without intervention, the recipient’s immune system recognizes the foreign D antigen and produces anti-D antibodies, which can cross the placenta in subsequent pregnancies to induce immune-mediated hemolysis, severe fetal anemia, hydrops fetalis, and hemolytic disease of the fetus and newborn
- glowm.com
Prophylactic management specifically targets unsensitized Rh-negative pregnant individuals, or non-immunized transfusion recipients, to block this humoral immune response before active antibody formation occurs
- uspreventiveservicestaskforce.org
Prophylactic management specifically targets unsensitized Rh-negative pregnant individuals, or non-immunized transfusion recipients, to block this humoral immune response before active antibody formation occurs
Personalize your experience
Follow Prevention of Rh incompatibility reaction and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.